Research Compound

Pinealon

Neuroprotective Tripeptide · MW 417.4 g/mol

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by researchers at the St. Petersburg Institute of Bioregulation and Gerontology. Research has examined its effects on pineal gland biology, circadian regulation, neuroprotection, and age-related cognitive decline in cell culture and animal models.

≥99% HPLC MS Confirmed 3rd Party Tested San Diego
Overview

What is Pinealon?

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by researchers at the St. Petersburg Institute of Bioregulation and Gerontology. Research has examined its effects on pineal gland biology, circadian regulation, neuroprotection, and age-related cognitive decline in cell culture and animal models.

Pinealon (Pinealon Tripeptide (Glu-Asp-Arg)) is supplied strictly as a reference material for in vitro and preclinical investigation. All characterization data described here is drawn from peer-reviewed literature and laboratory analysis; nothing herein constitutes a claim of clinical effect in humans.

Investigational Scope

Documented Research Areas

The following domains summarize directions explored across published studies and laboratory models. Each reflects observations reported in rodent models, in vitro systems, or the peer-reviewed record.

Neurological

Pineal Gland & Circadian Biology

Pinealon has been studied for its effects on pineal gland function and melatonin biosynthesis regulation in rodent models. Research has examined its role in circadian rhythm modulation and sleep-wake cycle regulation.

Neuroprotection

CNS Protective Mechanisms

Studies have examined Pinealon's neuroprotective effects in models of oxidative stress, hypoxia, and age-related neurodegeneration, with documented effects on neuronal survival markers.

Aging Biology

Cognitive Function Models

Russian research groups have examined Pinealon in aged rodent models, observing improvements in spatial memory and learning parameters alongside reductions in oxidative stress markers in brain tissue.

Epigenetic

Gene Expression & Chromatin

Research has examined Pinealon's ability to penetrate cell nuclei and interact with chromatin, suggesting potential epigenetic mechanisms underlying its observed biological activity in cell culture.

Proposed Mechanism

Mechanistic Pathway

Mechanistic steps below are hypothesized from in vitro assays and animal-model data reported in the literature. They describe biochemical interactions observed under controlled experimental conditions.

  1. 1

    Pineal Gland Regulation

    Research suggests Pinealon modulates pinealocyte activity and melatonin biosynthesis pathway components, with studies documenting changes in serotonin-N-acetyltransferase (SNAT) activity in pineal tissue.

  2. 2

    Antioxidant Defense Modulation

    Studies have documented Pinealon-mediated increases in superoxide dismutase and catalase activity in brain tissue of aged rodents, correlating with reduced lipid peroxidation markers.

  3. 3

    Neuronal Survival Signaling

    In vitro research has examined Pinealon's effects on neuronal survival under oxidative and hypoxic stress conditions, with observed upregulation of BDNF and anti-apoptotic protein expression.

  4. 4

    Nuclear Penetration & Chromatin Interaction

    Research has proposed that Pinealon, as a short peptide bioregulator, may interact directly with DNA regulatory sequences, modulating gene expression patterns relevant to neuronal function and aging.

Technical Data

Molecular Specifications

Amino Acid SequenceGlu-Asp-Arg
Molecular Weight417.4 g/mol
Molecular FormulaC₁₅H₂₅N₅O₈
CAS NumberN/A
Storage−20°C long-term, 4°C short-term up to 4 weeks
References

Selected Literature

The following peer-reviewed references informed the research summaries on this page. Citations are provided for scientific context only.

  1. Khavinson VK, et al. (2002). Peptide regulation of aging. Neuroendocrinology Letters, 23(1-2), 24–31.
  2. Khavinson VK & Morozov VG. (2003). Peptides of pineal gland and thymus prolong human life. Neuroendocrinology Letters, 24(3-4), 233–240.
  3. Sibarov DA, et al. (2017). Cytoprotective properties of tripeptide EDR and its analogues. Cell Biochemistry and Biophysics, 75(2), 175–183.
  4. Khavinson VK, et al. (2012). Short peptides and their role in aging biology. Biochemistry (Moscow), 77(5), 480–485.
  5. Yarygin KN, et al. (2014). Neural differentiation markers of stem cells under influence of short peptides. Bulletin of Experimental Biology and Medicine, 156(6), 792–795.

Research Disclaimer

This product is intended strictly for laboratory research purposes only. It is not a drug, food, cosmetic, or dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. It is not for human or animal consumption. All information presented is derived from published scientific literature and is provided for educational reference only. By purchasing, the buyer affirms they are a qualified researcher or institution and assume full responsibility for the safe and lawful handling of this material.